Earnings · US stocks
Oruka Therapeutics, Inc. (ORKA) earnings
Oruka Therapeutics, Inc. published its quarterly report on 2026-11-09. The stock moved +0.41% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-09
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +4.72% | — |
| 3 days | +0.41% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 3 of them. The stock rose in the 3 trading days after 6 of 8 reports (average +7.66%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-09 | -0.63 | -0.61% | +0.41% | — | — |
| 2026-08-10 | -0.55 | -9.95% | +8.68% | -5.50% | -5.54% |
| 2026-05-13 | -0.48 | +10.61% | -7.66% | +43.40% | +45.19% |
| 2026-03-12 | -0.45 | +26.89% | +29.13% | +115.79% | +108.60% |
| 2025-11-12 | -0.55 | -4.96% | -0.25% | +12.01% | +11.00% |
| 2025-08-11 | -0.46 | -6.36% | +14.94% | +19.23% | +14.94% |
| 2025-05-14 | -0.40 | +9.09% | +6.18% | +14.11% | +9.46% |
| 2025-03-06 | -0.49 | -18.55% | +9.83% | -8.44% | -0.36% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.